Tue.Sep 03, 2024

article thumbnail

Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change?

STAT

Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston, she had seen hundreds of kids with suspected urinary tract infections. Each time, she’d turn to a calculator, used by all Boston Children’s Hospital clinicians, to judge the youngest childrens’ risk. Did the infant have a high fever?

Hospitals 363
article thumbnail

FDA adcomm reform talks heat up

PharmaVoice

As the agency considers eliminating adcomm votes from the approval process, members vie to have their voices heard.

205
205
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades

STAT

Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive at the drug company G.D. Searle. She was told she had three years to live. Twenty-eight years later, Giusti, 65, is thriving. One reason is the patient advocacy group she founded in 1998: the Multiple Myeloma Research Foundation. The group has raised more than $600 million for research, launched nearly 100 clinical trials, and helped bring more than 15 new drugs to market.

article thumbnail

New research could ease concerns over suicide risk of obesity drugs

BioPharma Dive

While results from two after-the-fact analyses were “reassuring,” outside experts urged “continued vigilance” to ensure GLP-1 drugs don’t worsen problems in people with preexisting mental health conditions.

120
120
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: Letting funding for the All of Us research program lapse will cost the U.S. far more than it saves

STAT

I was in high school when I first encountered the ruthlessness of the number one killer in the U.S. A close friend of mine, then only 16 years old, witnessed his father having a heart attack while checking the mail. Despite desperate attempts at CPR on the driveway, he wasn’t able to save his dad, a seemingly healthy man in his early 40s. That event put me on a path to become a cardiologist.

Hospitals 362
article thumbnail

HDA 2024 Traceability Seminar: Legal Advice for DSCSA Compliance Teams

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar.

105
105

More Trending

article thumbnail

Making sustainability sustainable

Express Pharma

Prime Minister Narendra Modi’s mention of ‘green jobs’ in his Independence Day speech this year re-emphasised his commitment to achieving the Net Zero emissions target by 2070. The question is how will India, arguably the world’s third-largest greenhouse gas emitter, achieve this target, with even the goal of limiting global warming to an increase of no more than 1.5 degrees Celsius (1.5°C) above pre-industrial levels, looking like a steep challenge?

Packaging 100
article thumbnail

STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition

STAT

Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper, likely won’t satisfy many investors closely watching the AI drug developer.  The Salt Lake City company’s treatment is for cerebral cavernous malformation , or CCM, a potentially life-threatening condition that causes vessels in the brain to become enlarged and irregular, sometimes causing blood to leak into the brain or spinal cord.

article thumbnail

NPA warns of 'pharmacy deserts' in rural and deprived areas

The Pharmacist

Disproportionately low pharmacy provision and over-reliance on one pharmacy group could put rural areas at risk of becoming a 'pharmacy desert', the National Pharmacy Association (NPA) has warned. And above-average levels of closures in deprived areas risk widening health inequalities, the association added. In new analysis published today, the NPA found that 87% of local […] The post NPA warns of 'pharmacy deserts' in rural and deprived areas appeared first on The Pharmacist.

97
article thumbnail

STAT+: Vaxcyte shares boom as one of biotech’s big David vs. Goliath stories heats up

STAT

With new vaccine data released Tuesday, Vaxcyte, a San Carlos, Calif.-based firm, emerged as one of biotechnology’s hottest David-vs.-Goliath stories as the company seeks to challenge one of Pfizer’s biggest franchises: the Prevnar vaccine against pneumococcal disease. Shares in the company rocketed up 36% on the new data — released via press release — bringing the stock’s gain over the past 12 months to 115%.

Vaccines 290
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Zydus gains final USFDA approval for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg

Express Pharma

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Amantadine extended-release capsules, 68.5 mg, and tentative approval for 137 mg (USRLD: Gocovri (amantadine) extended-release capsules, 68.5 mg and 137 mg). Amantadine extended-release capsules are indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.

98
article thumbnail

STAT+: Drug aimed at strengthening neurons to treat Alzheimer’s fails in trial

STAT

A dark horse effort to treat Alzheimer’s disease, already marred by a data manipulation scandal, fell short in a randomized trial reported Tuesday afternoon. Athira Pharma said that Alzheimer’s patients who received its experimental injection fosgonimeton did not decline at a significantly slower rate than patients who received a placebo injection.

article thumbnail

Illumina avoids hefty EU fine over Grail merger

pharmaphorum

EU had no grounds to probe Illumina's takeover of Grail, says ECJ, but while spinoff has already taken place Illumina can now avoid a €432m fine

113
113
article thumbnail

Explore the clinical tools that use race to steer care

STAT

Every day, physicians use clinical algorithms to make decisions about the patients in their exam rooms. To help weigh a patient’s surgical risk or likelihood of disease, they factor in attributes such as blood pressure, age, weight, surgical history — and in some cases, a patient’s race. Like many clinical researchers, bioinformatician Shyam Visweswaran started learning about those race-based tools in 2020, when a catalyzing New England Journal of Medicine paper laid out 13

276
276
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

UAE MoHAP and Novo Nordisk partner for obesity management

Pharmaceutical Technology

The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scientific guide for obesity management and weight control.

107
107
article thumbnail

Why clinicians are reconsidering race-based algorithms

STAT

Algorithms are ubiquitous in medicine. They can take the form of a flowchart, a simple equation, or a complicated AI model, and are used to help clinicians diagnose diseases, predict the chances of survival, and determine if a patient is eligible for certain treatments. Many of these algorithms take a person’s race into account. For example, if the person is Black, a clinician may add or subtract a point from the patient’s score, which can affect their treatment.

266
266
article thumbnail

Why the Importer of Record (IoR) is vital in the clinical supply chain ­­

Pharmaceutical Technology

In clinical supplies, the Importer of Record (IoR) provides a critical service in facilitating logistics and easing the burden for sponsors.

104
104
article thumbnail

The biotech news you need to read this morning

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in multiple myeloma for decades, see mixed but promising results from Sanofi’s multiple sclerosis drug, and hear why All of Us should not be defunded.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

NHSE issues advice to pharmacies ahead of early release of prisoners

The Pharmacist

NHS England (NHSE) has issued advice on the role of community pharmacies in supporting individuals who will be released early from prison in the coming weeks. A letter from NHSE has flagged the potential for Pharmacy First and the Pharmacy Contraception Service to be used to support those being let out of prison as part […] The post NHSE issues advice to pharmacies ahead of early release of prisoners appeared first on The Pharmacist.

article thumbnail

STAT+: Greece’s antitrust regulator probes Novartis over practices tied to a pricey eye drug

STAT

Greece’s antitrust regulator is investigating allegations that, over a nine-year period, Novartis paid doctors and institutions to prescribe a pricey treatment for a serious eye disease and also disparaged rival medicines. In a brief statement, the Hellenic Competition Commission disclosed it is probing evidence the company paid physicians for travel to conferences and participation in studies in order to boost sales of Lucentis, which is used to treat age-related macular degeneration, a

262
262
article thumbnail

How to Scale Your Business with a CDMO

Drug Patent Watch

Scaling your business with a Contract Development and Manufacturing Organization (CDMO) is crucial for biopharmaceutical companies seeking to expedite the transition from preclinical development to clinical manufacturing. CDMOs play a vital role in providing expertise in process development and scale-up manufacturing, allowing biotech companies to adapt to changing market dynamics and client needs.

90
article thumbnail

STAT+: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’

STAT

Laurie H. Glimcher, chief executive of Dana-Farber Cancer Institute, said she would step down next month, ending an eight-year run capped by her  surprise split  with Dana-Farber’s longtime partner, Brigham and Women’s Hospital, and decision to build a cancer center with Beth Israel Deaconess Medical Center. Benjamin L. Ebert, chair of Dana-Farber’s medical oncology department and a prize-winning researcher, will take over from Glimcher on Oct. 1, the Boston instit

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Digital NHS health checks will start in England next year

pharmaphorum

A digital version of the NHS Health Check offered to older people in the UK will be piloted in some areas of England early next year, according to the government.The Department of Health and Social Care (DHSC) has said the digital alternative to the current system of in-person health checks will be ready for testing in early 2025, with pilots planned for Norfolk, Medway, and Lambeth in London.

97
article thumbnail

STAT+: European court sides with Illumina, saying regulators overstepped in scrutiny of Grail deal

STAT

LONDON — Europe’s top court on Tuesday ruled that regulators overstepped in challenging the DNA sequencing behemoth Illumina’s acquisition of Grail, finding that the European Commission did not have jurisdiction over the deal.  The decision won’t have a major impact on the Illumina-Grail relationship, with Illumina having divested the cancer screening company over the summer.

235
235
article thumbnail

ENTOD’s PresVu eye drops gain DCGI approval

Express Pharma

ENTOD Pharmaceuticals has received final approval from the Drug Controller General of India (DCGI) for its eye drops, PresVu, for presbyopia. This approval follows an earlier recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). PresVu aims to reduce dependency on reading glasses for individuals affected by presbyopia, a common age-related vision condition that typically impacts those over 40.

88
article thumbnail

A STAT Investigation: Embedded Bias

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Good morning! You know that part of “Little Women” (2019) when Jo says “I can’t believe that childhood is over,” while collapsed on the ground at her sister’s feet? That’s how I feel about summer ending.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Skyline wins orphan drug designation for retinitis pigmentosa gene therapy

Pharmaceutical Technology

There are currently no approved treatments that can halt or reverse photoreceptor degeneration in patients with retinitis pigmentosa.

98
article thumbnail

MK Hamied, Vice Chairman and Non-Executive Director, Cipla steps down

Express Pharma

On Tuesday, September 3, 2024, Cipla announced that MK Hamied has resigned as Vice Chairman with effect from close of business hours on October 29, 2024 due to his age and health. “It is with a heavy heart that I write to formally announce my resignation from the position of Vice Chairman and Non-Executive Director of the company,” he said in a letter to the board of directors.

87
article thumbnail

Data builds behind Valneva, Pfizer's Lyme disease vaccine

pharmaphorum

New data for Valneva and Pfizer's Lyme disease vaccine bolsters the case for the shot as the results of a phase 3 programme are awaited.

Vaccines 105
article thumbnail

Metagenomics revolution: Empress Therapeutics on drug discovery breakthroughs

Outsourcing Pharma

Dr Dawn Thompson has over 20 years of experience in building technology platforms that leverage genomics at scale to produce novel products.

100
100
article thumbnail

Unpacking the High Cost of GLP-1 Drugs

Pharmaceutical Commerce

How can industry stakeholders ensure the quality and supply chain security of existing product?

111
111